Lori Fiessinger, MD

If you would like to schedule an appointment with Dr. Fiessinger, please call:

(612) 625-5656 - Clinics and Surgery Center

(763) 898-1440 - M Health Maple Grove Clinic

My goal is to provide my patients with high quality, individualized and evidence-based care. I see a wide variety of patients in my practice, including general dermatology, cosmetic dermatology, and high-risk skin cancer patients, with a special interest in the diagnosis and treatment of melanoma. I have joined several colleagues within the University of Minnesota Health healthcare system to form a multidisciplinary team of providers that diagnose and treat patients with high-risk skin cancers. I specialize in the care of patients that have a higher risk of developing melanoma and those diagnosed with melanoma.

WDS, Editorial Committee, Committee Member 2020 - Present

WDS, Practice Advisory, Committee Member 2019 – Present

AAD, Community Outreach, Committee Member 2019 – Present

Association of Professors of Dermatology, Member 2018 – Present

Women’s Dermatologic Society (WDS), Member 2017 – Present

American Society for Laser Medicine and Surgery (ASLMS), Member 2017 – Present

American Academy of Dermatology (AAD), Member 2015 – Present

American Society of Dermatologic Surgery (ASDS), Member  2015-Present

1.Scott JF, Vyas R, Galvin J, Gotow E, Fiessinger LA, Gerstenblith AT, Gerstenblith MR. Clin Primary bilateral uveal melanoma: a population-based study and systematic review. Exp Ophthalmol. 2018 Jul;46(5):502-510. PMID: 29219254

2.Soler DC, Young AB, Fiessinger LA, Galimberti F, Debanne S, Groft S, McCormick TS, Cooper KD. Increased, but functionally impaired, CD14+ HLA-DRneg/low Myeloid-Derived Suppressor Cells in psoriasis; a mechanism of dysregulated T cells. J Invest Dermatol. 2016 Apr;136(4):798-808. PMID: 26807516

3.Stallings AM, Velez MW, Fiessinger LA, Piliang MP, Mesinkovska NA, Kyei A, Bergfeld WF. ILK Index and Regrowth in Alopecia Areata. J Investig Dermatol Symp Proc. 2015 Nov;17(2):47-9. PMID: 26551947

4.Fiessinger LA, Petukhova TA, Gerstenblith MR, Honda K, McCormick TS, Cooper KD Quantification of MDSCs within primary melanoma tumors. Pigment Cell & Melanoma Research. 2013 Oct;26(6):950

5.Zimmerer JM, Horne PH, Fiessinger LA, Fisher MG, Jayashankar K, Garcia SF, Abdel-Rasoul M, van Rooijen N, Bumgardner GL. Inhibition of recall responses through complementary therapies targeting CD8+ T cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients. Cell Transplantation, 2013; 22(7), 1157-69. PMID: 23069206

6.Zimmerer JM, Horne PH, Fiessinger LA, Fisher MG, Pham TA, Saklayen SL, Bumgardner GL. Cytotoxic effector function of CD4-independent, CD8+ T cells is mediated by TNF-alpha/TNFR. Transplantation, 2012; 94(11), 1103-10. PMID: 23222736